Neuromodulation for metabolic conditions or syndromes
US10856926B2 · kind B2 · utility
7Cited by
353References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2018 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Jun 21, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.